HK1123793A1 - Hydrates of alkaline-earth salts of irbesartan and the preparation thereof - Google Patents
Hydrates of alkaline-earth salts of irbesartan and the preparation thereofInfo
- Publication number
- HK1123793A1 HK1123793A1 HK09101566.3A HK09101566A HK1123793A1 HK 1123793 A1 HK1123793 A1 HK 1123793A1 HK 09101566 A HK09101566 A HK 09101566A HK 1123793 A1 HK1123793 A1 HK 1123793A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- irbesartan
- hydrates
- alkaline
- preparation
- earth salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0505755A FR2886642B1 (fr) | 2005-06-06 | 2005-06-06 | Sels alcalino-terreux d'irbesartan et leur preparation |
| PCT/FR2006/001267 WO2006131632A1 (fr) | 2005-06-06 | 2006-06-06 | Hydrates de sels alcalino-terreux d'irbesartan et leur preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1123793A1 true HK1123793A1 (en) | 2009-06-26 |
Family
ID=35639476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK09101566.3A HK1123793A1 (en) | 2005-06-06 | 2009-02-18 | Hydrates of alkaline-earth salts of irbesartan and the preparation thereof |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7947842B2 (ja) |
| EP (1) | EP1891054A1 (ja) |
| JP (1) | JP2008542435A (ja) |
| KR (1) | KR20080024473A (ja) |
| CN (1) | CN101248061B (ja) |
| AR (1) | AR054131A1 (ja) |
| AU (1) | AU2006256678A1 (ja) |
| BR (1) | BRPI0610933A2 (ja) |
| CA (1) | CA2610665A1 (ja) |
| FR (1) | FR2886642B1 (ja) |
| HK (1) | HK1123793A1 (ja) |
| IL (1) | IL187723A (ja) |
| MX (1) | MX2007015426A (ja) |
| RU (1) | RU2401266C2 (ja) |
| TW (1) | TW200716099A (ja) |
| UY (1) | UY29584A1 (ja) |
| WO (1) | WO2006131632A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008018843A1 (en) * | 2006-08-08 | 2008-02-14 | Ulkar Kimya Sanayi Ve Ticaret As | Process for producing useful salts form of biphenyl-tetrazole compounds |
| CN111175385B (zh) * | 2018-11-12 | 2023-02-07 | 珠海润都制药股份有限公司 | 一种厄贝沙坦中厄贝沙坦同分异构体检验方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT97078B (pt) * | 1990-03-20 | 1997-07-31 | Sanofi Sa | Processo para a preparacao de derivados heterociclicos n-substituidos e de composicoes farmaceuticas que os contem |
| US5270317A (en) * | 1990-03-20 | 1993-12-14 | Elf Sanofi | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| US5541209A (en) * | 1994-08-22 | 1996-07-30 | Bristol-Myers Squibb Company | Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative |
| CN1216873C (zh) | 2000-07-19 | 2005-08-31 | 诺瓦提斯公司 | 缬沙坦的盐 |
| CN1548421A (zh) * | 2003-05-22 | 2004-11-24 | 上海医药工业研究院 | 替米沙坦盐及其制备方法 |
| SI21849A (sl) * | 2004-07-29 | 2006-02-28 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Priprava hidrokloridnih soli tetrazolskega derivata |
-
2005
- 2005-06-06 FR FR0505755A patent/FR2886642B1/fr not_active Expired - Fee Related
-
2006
- 2006-06-02 AR ARP060102315A patent/AR054131A1/es not_active Application Discontinuation
- 2006-06-05 TW TW095119885A patent/TW200716099A/zh unknown
- 2006-06-06 BR BRPI0610933-0A patent/BRPI0610933A2/pt not_active IP Right Cessation
- 2006-06-06 KR KR1020077028374A patent/KR20080024473A/ko not_active Application Discontinuation
- 2006-06-06 JP JP2008515246A patent/JP2008542435A/ja active Pending
- 2006-06-06 EP EP06764732A patent/EP1891054A1/fr not_active Withdrawn
- 2006-06-06 CN CN2006800198798A patent/CN101248061B/zh not_active Expired - Fee Related
- 2006-06-06 CA CA002610665A patent/CA2610665A1/fr not_active Abandoned
- 2006-06-06 RU RU2007149526/04A patent/RU2401266C2/ru not_active IP Right Cessation
- 2006-06-06 AU AU2006256678A patent/AU2006256678A1/en not_active Abandoned
- 2006-06-06 MX MX2007015426A patent/MX2007015426A/es active IP Right Grant
- 2006-06-06 WO PCT/FR2006/001267 patent/WO2006131632A1/fr active Application Filing
- 2006-06-07 UY UY29584A patent/UY29584A1/es unknown
-
2007
- 2007-11-28 IL IL187723A patent/IL187723A/en not_active IP Right Cessation
- 2007-12-05 US US11/950,555 patent/US7947842B2/en active Active
-
2009
- 2009-02-18 HK HK09101566.3A patent/HK1123793A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007015426A (es) | 2008-02-19 |
| IL187723A0 (en) | 2008-08-07 |
| CN101248061A (zh) | 2008-08-20 |
| US20080096944A1 (en) | 2008-04-24 |
| EP1891054A1 (fr) | 2008-02-27 |
| TW200716099A (en) | 2007-05-01 |
| KR20080024473A (ko) | 2008-03-18 |
| WO2006131632A1 (fr) | 2006-12-14 |
| IL187723A (en) | 2011-06-30 |
| CN101248061B (zh) | 2011-08-24 |
| UY29584A1 (es) | 2007-01-31 |
| US7947842B2 (en) | 2011-05-24 |
| JP2008542435A (ja) | 2008-11-27 |
| RU2401266C2 (ru) | 2010-10-10 |
| CA2610665A1 (fr) | 2006-12-14 |
| FR2886642A1 (fr) | 2006-12-08 |
| AR054131A1 (es) | 2007-06-06 |
| FR2886642B1 (fr) | 2008-05-30 |
| RU2007149526A (ru) | 2009-07-20 |
| BRPI0610933A2 (pt) | 2010-08-03 |
| AU2006256678A1 (en) | 2006-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL244442B (en) | Compounds of converted acylanilides and their use | |
| GB0718972D0 (en) | Compounds and methods of making the compounds | |
| IL185199A0 (en) | Indole compound and use thereof | |
| IL184036A0 (en) | Preparation of rosuvastatin | |
| ZA200710877B (en) | Preparation of syngas | |
| EP2023718A4 (en) | CREATINLIGATE COMPOUNDS AND APPLICATION METHOD THEREFOR | |
| ZA200903401B (en) | The uses of the carboxy-amido-triazole compounds and salts thereof | |
| IL190953A0 (en) | Cyclopropylacetic acid derivatives and use thereof | |
| IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
| EP1893625A4 (en) | PROCESS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES | |
| HK1161122A1 (en) | Use of 24-norudca 24-norudca | |
| EP1921066A4 (en) | PYRIDYLPHENOL COMPOUND AND USE THEREOF | |
| EP1857104A4 (en) | USE OF A CINNAMOYL COMPOUND | |
| PL380561A1 (pl) | Sposób otrzymywania pochodnych antracyklin | |
| EP1931370A4 (en) | USE OF DES-ASPARTATE-ANGIOTENSIN I | |
| HK1123793A1 (en) | Hydrates of alkaline-earth salts of irbesartan and the preparation thereof | |
| IL192820A0 (en) | Novel compounds and use thereof | |
| IL187948A0 (en) | Preparation of rosuvastatin | |
| GB0519891D0 (en) | Pharmaceutically acceptable salts and hydrates | |
| GB0515430D0 (en) | Preparation of cabergoline | |
| ZA200706203B (en) | Processes and compounds for the preparation of substituted naphthylindole derivatives | |
| HU0500463D0 (en) | Pyridinyl derivatives of dialkyl-oxindoles | |
| HU0500462D0 (en) | Pyridinyl derivatives of alkyl-oxindoles | |
| ZA200710971B (en) | Elasmobranch-repelling compounds and methods of use | |
| ZA200707126B (en) | Indole compound and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20150606 |